Abstract:AIM To develop a rapid and sensitive liquid chromatography-tandem mass spectrometric (LC-MS/MS) method for the simultaneous quantitation of lansoprazol.e and its metabolites 5'-hydroxy lansoprazole and lansoprazole sulphone in human plasma.METHODS After a simple protein precipitation using acetonitrile,the analytes and internal standard (IS),omeprazole,were separated on a Zorbax SB-C18 NarrowBore column using methanol -10 mmol·L-1 ammonium acetate (65:35,V/V) as mobile phase at a flow rate of 0.4 mL ·min-1 Detection was by electrospray negative ionization mass spectrometry using multiple reaction monitoring (MRM) mode.RESULTS Lansoprazole,5'-hydroxy lansoprazole,lansoprazole sulphone and IS were eluted at 2.63, 1.56,2.21, and 2.30 rain,respectively.The method was linear in the concentration ranges of 2.00 - 800 μg·L-1 for lansoprazole,1.00 - 400 μg·L-1 for 5'-hydroxy lansoprazole and 0.200 -80.0 μg ·L-1 for lansoprazole sulphone,with intra- and inter-day precision as relative standard deviation (RSD) ＜ 8.0％ and accuracy as relative error (RE) within ± 6.0％.The extraction recoveries were high and reproducible. Lansoprazole,5'-hydroxy lansoprazole, and lansoprazole sulphone were found to be stable under various stoage conditions. The method was successfully applied to a pharmacokinetic study in healthy Chinese volunteers after a single oral dose of lansoprazole enteric-coated tablets, in which theρmax values were 165-1400, 15.8-177, and 10.2-530μg·L-1, and the AUC0-t values were 651-7189, 99.3-639, and 20.5-4372 μ·h·L-1 for lansoprazole,5'-hydroxy lansoprazole, and lansoprazole sulphone, respectively. There was significant inter-individual difference in the pharmacokinetics of lansoprazole and its metabolites. CONCLUSION The established method is rapid, sensitive, selective, reliable and sufficient for pharmacokinetic study of lansoprazole and its metabolites.

Development and validation of a highly sensitive and selective LC-MS/MS method for the determination of 15-hydroxylubiprostone in human plasma: application to a pharmacokinetic study in healthy Chinese volunteers

Efficacy and Safety of Lubiprostone for the Treatment of Functional Constipation in Chinese Adult Patients: A Multicenter, Randomized, Double‐blind, Placebo‐controlled Trial

Optimization of Solid-Phase Extraction and Liquid Chromatography-Tandem Mass Spectrometry for Simultaneous Determination of Capilliposide B and Its Active Metabolite in Rat Urine and Feces: Overcoming Nonspecific Binding.

Determination of duloxetine in human plasma via LC/MS and subsequent application to a pharmacokinetic study in healthy Chinese volunteers.

A Sensitive HPLC-MS/MS Method for Determination of Obeticholic Acid in Human Plasma: Application to a Pharmacokinetic Study in Healthy Volunteers

Development and Validation of A Lc-Ms/Ms Method for the Determination of Clebopride and Its Application to A Pharmacokinetics Study in Healthy Chinese Volunteers

UPLC-MS/MS-Based Target Screening of 90 Phosphodiesterase Type 5 Inhibitors in 5 Dietary Supplements

Overcoming the challenge of potent endogenous interferences in limaprost quantification: An innovative methodology combining differential mobility spectrometry with LC-MS/MS for ultra-high sensitivity, selectivity and significantly enhanced throughput

Study on pharmacokinetics of eight active compounds from Bufei-Huoxue Capsule based on UHPLC-MS/MS

Simultaneous determination of amoxicillin and ambroxol in human plasma by LC-MS/MS: validation and application to pharmacokinetic study

Determination of Lansoprazole in Human Plasma by Rapid Resolution Liquid Chromatography–electrospray Tandem Mass Spectrometry: Application to a Bioequivalence Study on Chinese Volunteers

A sensitive and high-throughput LC-ESI-MS/MS method to detect budesonide in human plasma: application to an evaluation of pharmacokinetics of budesonide intranasal formulations with and without charcoal-block in healthy volunteers

Development and Validation of an LC-MS/MS Method for the Determination of a Novel Thienoquinolin Urea Transporter Inhibitor PU-48 in Rat Plasma and Its Application to a Pharmacokinetic Study.

LC-MS/MS Method for Simultaneous Quantitation of Lansoprazole and Its Metabolites in Human Plasma and Application to a Pharmacokinetic Study

Determination of Levonorgestrel in Human Plasma by Liquid Chromatography-Tandem Mass Spectrometry Method: Application to A Bioequivalence Study of Two Formulations in Healthy Volunteers

Determination concentration of duloxetine hydrochloride in human plasma by HPLC-MS/MS and study on its pharmacokinetics

Pharmacokinetics and Bioavailability Study of Fluoxetine Hydrochloride Capsules in Chinese Healthy Volunteers by LC-MS/MS Method

Development and validation of ultra-performance liquid chromatography-tandem mass spectrometric methods for simultaneous and rapid determination of contezolid and its major metabolite M2 in plasma and urine samples and its application to a study in subjects with moderate liver impairment

High-Throughput Determination of Carbocysteine in Human Plasma by Liquid Chromatography/Tandem Mass Spectrometry: Application to A Bioequivalence Study of Two Formulations in Healthy Volunteers

HPLC-MS/MS method for determination of bezafibrate concentration in human plasma and its pharmacokinetics in healthy volunteers

A validated LC-MS/MS method for the determination of RAF inhibitor LXH254: Application to pharmacokinetic study in rat